Rigel Pharmaceuticals
XNAS: RIGL
Rigel Pharmaceuticals Live Share Price Today, Share Analysis and Chart
about
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsi...
Read More
19.34
-0.01
(-0.05%)
1,640
XNAS Volume
XNAS 15 Jul, 2025 9:32 AM (EDT)
High Financial Strength
Affordable Valuation
Technically Neutral
Strong Performer, Under Radar
These stocks are with good quality scores and with strong financials. They are affordably priced stocks and can give good returns
View Similar
Embed DVM
Rigel Pharmaceuticals Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..